長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4570】免疫生物研究所

【4570】免疫生物研究所
研究用試薬。
類似企業：


東証グロース
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/11 Q2予 925 → 0.0% 0.0% 120 → 0.0% 0.0% 120 → 0.0% 0.0% 115 → 0.0% 0.0%
2025.03 2024/08/08 Q1予 925 → 0.0% 0.0% 120 → 0.0% 0.0% 120 → 0.0% 0.0% 115 → 0.0% 0.0%
2025.03 2024/05/14 当初予 925 - - - 120 - - - 120 - - - 115 - - -
2024.03 2024/05/14 実 816 → 0.0% -4.0% 104 → 0.0% +15.6% 125 → 0.0% +38.9% 186 → 0.0% +132.5%
2024.03 2024/05/10 修正予 816 ↓ -4.0% -4.0% 104 ↑ +15.6% +15.6% 125 ↑ +38.9% +38.9% 186 ↑ +132.5% +132.5%
2024.03 2024/02/02 Q3予 850 → 0.0% 0.0% 90 → 0.0% 0.0% 90 → 0.0% 0.0% 80 → 0.0% 0.0%
2024.03 2023/11/02 Q2予 850 → 0.0% 0.0% 90 → 0.0% 0.0% 90 → 0.0% 0.0% 80 → 0.0% 0.0%
2024.03 2023/08/07 Q1予 850 → 0.0% 0.0% 90 → 0.0% 0.0% 90 → 0.0% 0.0% 80 → 0.0% 0.0%
2024.03 2023/05/12 当初予 850 - - - 90 - - - 90 - - - 80 - - -
2023.03 2023/05/12 実 794 → 0.0% +2.5% 58 → 0.0% +1833.3% -149 ↓ -17.3% -56.8% -289 → 0.0% -140.8%
2023.03 2023/04/27 修正予 794 ↑ +2.5% +2.5% 58 ↑ +1833.3% +1833.3% -127 ↓ -33.7% -33.7% -289 ↓ -140.8% -140.8%
2023.03 2023/02/06 Q3予 775 → 0.0% 0.0% 3 → 0.0% 0.0% -95 → 0.0% 0.0% -120 → 0.0% 0.0%
2023.03 2022/11/04 Q2予 775 → 0.0% 0.0% 3 → 0.0% 0.0% -95 → 0.0% 0.0% -120 → 0.0% 0.0%
2023.03 2022/08/05 Q1予 775 → 0.0% 0.0% 3 → 0.0% 0.0% -95 → 0.0% 0.0% -120 → 0.0% 0.0%
2023.03 2022/05/13 当初予 775 - - - 3 - - - -95 - - - -120 - - -
2022.03 2022/05/13 実 647 ↑ +0.3% -16.0% -122 ↑ +4.7% -14.0% -243 ↑ +1.2% -57.8% -258 ↓ -1.2% -59.3%
2022.03 2022/03/15 修正予 645 ↓ -16.2% -16.2% -128 ↓ -19.6% -19.6% -246 ↓ -59.7% -59.7% -255 ↓ -57.4% -57.4%
2022.03 2022/02/04 Q3予 770 → 0.0% 0.0% -107 → 0.0% 0.0% -154 → 0.0% 0.0% -162 → 0.0% 0.0%
2022.03 2021/11/05 Q2予 770 → 0.0% 0.0% -107 → 0.0% 0.0% -154 → 0.0% 0.0% -162 → 0.0% 0.0%
2022.03 2021/08/06 Q1予 770 → 0.0% 0.0% -107 → 0.0% 0.0% -154 → 0.0% 0.0% -162 → 0.0% 0.0%
2022.03 2021/05/14 当初予 770 - - - -107 - - - -154 - - - -162 - - -
2021.03 2021/05/14 実 602 ↑ +9.7% +9.7% -240 ↑ +22.1% +22.1% -310 ↑ +24.4% +24.4% -318 ↑ +26.0% +26.0%
2021.03 2021/02/12 Q3予 549 → 0.0% 0.0% -308 → 0.0% 0.0% -410 → 0.0% 0.0% -430 → 0.0% 0.0%
2021.03 2020/11/06 Q2予 549 → 0.0% 0.0% -308 → 0.0% 0.0% -410 → 0.0% 0.0% -430 → 0.0% 0.0%
2021.03 2020/08/07 Q1予 549 → 0.0% 0.0% -308 → 0.0% 0.0% -410 → 0.0% 0.0% -430 → 0.0% 0.0%
2021.03 2020/08/06 当初予 549 - - - -308 - - - -410 - - - -430 - - -
2020.03 2020/05/14 実 576 ↑ +1.9% -41.9% -595 ↑ +8.5% -52.2% -678 ↑ +7.1% -23.3% -668 ↑ +10.3% -18.2%
2020.03 2020/03/17 修正予 565 ↓ -15.7% -43.0% -650 ↓ -27.5% -66.2% -730 ↓ -14.1% -32.7% -745 ↓ -13.7% -31.9%
2020.03 2020/02/07 Q3予 670 → 0.0% -32.4% -510 → 0.0% -30.4% -640 → 0.0% -16.4% -655 → 0.0% -15.9%
2020.03 2019/11/08 Q2予 670 ↓ -32.4% -32.4% -510 ↓ -30.4% -30.4% -640 ↓ -16.4% -16.4% -655 ↓ -15.9% -15.9%
2020.03 2019/08/02 Q1予 991 → 0.0% 0.0% -391 → 0.0% 0.0% -550 → 0.0% 0.0% -565 → 0.0% 0.0%
2020.03 2019/05/14 当初予 991 - - - -391 - - - -550 - - - -565 - - -
2019.03 2019/05/14 実 781 ↑ +0.1% -20.5% -173 ↓ -15.3% -592.0% -155 ↓ -15.7% -545.8% -167 ↓ -11.3% -328.2%
2019.03 2019/03/22 修正予 780 ↓ -20.6% -20.6% -150 ↓ -500.0% -500.0% -134 ↓ -458.3% -458.3% -150 ↓ -284.6% -284.6%
2019.03 2019/02/01 Q3予 982 → 0.0% 0.0% -25 → 0.0% 0.0% -24 → 0.0% 0.0% -39 → 0.0% 0.0%
2019.03 2018/11/05 Q2予 982 → 0.0% 0.0% -25 → 0.0% 0.0% -24 → 0.0% 0.0% -39 → 0.0% 0.0%
2019.03 2018/08/03 Q1予 982 → 0.0% 0.0% -25 → 0.0% 0.0% -24 → 0.0% 0.0% -39 → 0.0% 0.0%
2019.03 2018/05/14 当初予 982 - - - -25 - - - -24 - - - -39 - - -
2018.03 2018/05/14 実 758 ↑ +1.7% -1.9% -48 ↑ +31.4% +58.6% -49 ↑ +34.7% +59.8% -52 ↑ +33.3% +59.4%
2018.03 2018/03/16 修正予 745 ↓ -3.6% -3.6% -70 ↑ +39.7% +39.7% -75 ↑ +38.5% +38.5% -78 ↑ +39.1% +39.1%
2018.03 2018/02/02 Q3予 773 → 0.0% 0.0% -116 → 0.0% 0.0% -122 → 0.0% 0.0% -128 → 0.0% 0.0%
2018.03 2017/11/02 Q2予 773 → 0.0% 0.0% -116 → 0.0% 0.0% -122 → 0.0% 0.0% -128 → 0.0% 0.0%
2018.03 2017/08/04 Q1予 773 → 0.0% 0.0% -116 → 0.0% 0.0% -122 → 0.0% 0.0% -128 → 0.0% 0.0%
2018.03 2017/05/12 当初予 773 - - - -116 - - - -122 - - - -128 - - -
2017.03 2017/05/12 実 741 → 0.0% -7.4% -1,156 → 0.0% -542.2% -1,170 → 0.0% -550.0% -2,094 → 0.0% -1002.1%
2017.03 2017/05/10 修正予 741 ↓ -7.4% -7.4% -1,156 ↓ -542.2% -542.2% -1,170 ↓ -550.0% -550.0% -2,094 ↓ -1002.1% -1002.1%
2017.03 2017/02/03 Q3予 800 → 0.0% 0.0% -180 → 0.0% 0.0% -180 → 0.0% 0.0% -190 → 0.0% 0.0%
2017.03 2016/11/04 Q2予 800 → 0.0% 0.0% -180 → 0.0% 0.0% -180 → 0.0% 0.0% -190 → 0.0% 0.0%
2017.03 2016/08/04 Q1予 800 → 0.0% 0.0% -180 → 0.0% 0.0% -180 → 0.0% 0.0% -190 → 0.0% 0.0%
2017.03 2016/05/13 当初予 800 - - - -180 - - - -180 - - - -190 - - -
2016.03 2016/05/13 実 717 → 0.0% -20.3% -75 → 0.0% -114.3% -81 → 0.0% -62.0% -31 → 0.0% -255.0%
2016.03 2016/05/09 修正予 717 ↓ -1.8% -20.3% -75 ↑ +34.8% -114.3% -81 ↑ +32.5% -62.0% -31 ↑ +43.6% -255.0%
2016.03 2016/02/05 Q3予 730 → 0.0% -18.9% -115 → 0.0% -228.6% -120 → 0.0% -140.0% -55 → 0.0% -375.0%
2016.03 2015/11/06 Q2予 730 ↓ -18.9% -18.9% -115 ↓ -228.6% -228.6% -120 ↓ -140.0% -140.0% -55 ↓ -375.0% -375.0%
2016.03 2015/08/04 Q1予 900 → 0.0% 0.0% -35 - - - -50 → 0.0% 0.0% 20 → 0.0% 0.0%
2016.03 2015/05/13 当初予 900 - - - - - - - -50 - - - 20 - - -
2015.03 2015/05/13 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/06 Q3予 700 → 0.0% -22.2% -170 → 0.0% -1800.0% -140 → 0.0% -1500.0% -150 → 0.0% -5100.0%
2015.03 2014/12/19 修正予 700 ↓ -22.2% -22.2% -170 ↓ -1800.0% -1800.0% -140 ↓ -1500.0% -1500.0% -150 ↓ -5100.0% -5100.0%
2015.03 2014/11/07 Q2予 900 → 0.0% 0.0% 10 → 0.0% 0.0% 10 → 0.0% 0.0% 3 → 0.0% 0.0%
2015.03 2014/08/05 Q1予 900 → 0.0% 0.0% 10 → 0.0% 0.0% 10 → 0.0% 0.0% 3 → 0.0% 0.0%
2015.03 2014/05/13 当初予 900 - - - 10 - - - 10 - - - 3 - - -
2014.03 2014/05/13 実 670 → 0.0% 0.0% -107 → 0.0% 0.0% -99 → 0.0% 0.0% -114 → 0.0% 0.0%
2014.03 2014/05/02 当初予 670 - - - -107 - - - -99 - - - -114 - - -
シェア ツイート
ページトップへ戻る